Medpace Holdings Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Medpace Holdings, Inc. income statement - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue2.532.111.891.461.140.930.860.70
Cost of Revenue1.770.681.360.530.440.350.620.49
Gross Profit0.761.430.520.930.700.570.250.22
Operating Expenses
Research & Development0.000.000.000.000.000.000.000.00
Selling, General & Administrative0.200.180.160.130.110.090.100.08
Operating Expenses0.230.980.190.650.500.400.120.11
Operating Income0.530.450.340.280.200.170.130.10
Other Income/Expense
Interest Income0.000.020.000.000.000.000.000.00
Interest Expense0.000.000.000.000.000.000.000.01
Other Income/Expense0.010.000.000.000.000.000.000.00
Income
Income Before Tax0.540.480.340.280.200.170.120.09
Income Tax Expense0.090.070.050.040.020.020.020.02
Net Income0.450.400.280.250.180.150.100.07
Net Income - Continuous Operations0.450.400.280.250.180.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.000.00
EBITDA0.570.480.380.300.220.190.150.14
EBIT0.000.450.340.280.200.170.120.10
Depreciation & Amortization0.030.030.030.020.020.020.020.04
Earnings Per Share
Basic EPS16.0013.009.008.005.004.003.002.00
Diluted EPS15.0013.009.007.005.004.003.002.00
Basic Shares Outstanding0.030.030.030.030.040.040.040.04
Diluted Shares Outstanding0.030.030.030.030.040.040.040.04